Lv1
70 积分 2023-08-29 加入
Metabolic dysfunction-associated steatotic liver disease and steatohepatitis-associated hepatocarcinoma preclinical models
1个月前
已完结
Puerarin alleviates atherosclerosis via the inhibition of Prevotella copri and its trimethylamine production
1个月前
已完结
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
1个月前
已完结
Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management
1个月前
已完结
Global burden of metabolic dysfunction-associated steatotic liver disease, 1990–2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023
1个月前
已完结
Metabolic Dysfunction-Associated Steatohepatitis in the Middle East: Clinical Challenges and Strategies to Bridge the Gap
1个月前
已关闭
皖公网安备34019202002308
